Tolerance Bio will increase health span by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance News & UPDATES Featured October 27, 2025 Tolerance Bio’s Implanted iPSC-derived Thymic Organoids Enable In Vivo Positive Selection of Human T cells and Tumor Burden Reduction in Melanoma October 27, 2025 Read more → October 27, 2025 September 8, 2025 Tolerance Bio and ZipCode Bio Announce Strategic R&D Collaboration to Advance Targeted Thymus Therapeutics September 8, 2025 Read more → September 8, 2025 December 19, 2024 Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases December 19, 2024 Read more → December 19, 2024
